Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in microtubule-stabilizing agents
Yanan Cao, Lingli Zheng, Dan Wang, et al.
European Journal of Medicinal Chemistry (2017) Vol. 143, pp. 806-828
Closed Access | Times Cited: 152

Showing 26-50 of 152 citing articles:

Molecular Link between DNA Damage Response and Microtubule Dynamics
Jeong‐Ki Min
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6986-6986
Open Access | Times Cited: 23
Synthesis and Antiproliferative Activity of Steroidal Diaryl Ethers
Édua Kovács, H. Abu Ali, Renáta Minorics, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1196-1196
Open Access | Times Cited: 12
Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
Silvia Voci, Agnese Gagliardi, Roberto Molinaro, et al.
Gels (2021) Vol. 7, Iss. 2, pp. 33-33
Open Access | Times Cited: 27
Recent development of BTK-based dual inhibitors in the treatment of cancers
Fansheng Ran, Yun Liu, Zhongyuan Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114232-114232
Closed Access | Times Cited: 21
Synthesis, biological evaluation, and molecular docking investigation of 3-amidoindoles as potent tubulin polymerization inhibitors
Peng Chen, Yuxin Zhuang, Peng-Cheng Diao, et al.
European Journal of Medicinal Chemistry (2018) Vol. 162, pp. 525-533
Closed Access | Times Cited: 37
Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin
Fatima Naaz, Faiz Ahmad, Bilal Ahmad Lone, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103519-103519
Closed Access | Times Cited: 32
Novel taxanes in development: Hopes or hypes?
Lei Lei, Xiaojia Wang, Shou‐Ching Tang
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103727-103727
Open Access | Times Cited: 16
Dual targeted 2-Benzylideneindanone pendant hydroxamic acid group exhibits selective HDAC6 inhibition along with tubulin stabilization effect
Kapil Kumar, Ranjana Das, Barsha Thapa, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 86, pp. 117300-117300
Open Access | Times Cited: 9
Allosteric Modulators of Protein–Protein Interactions (PPIs)
Duan Ni, Na Liu, Chunquan Sheng
Advances in experimental medicine and biology (2019), pp. 313-334
Closed Access | Times Cited: 29
Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis
A. Gupta, Sonam Tulsyan, Mausumi Bharadwaj, et al.
Topics in Current Chemistry (2019) Vol. 377, Iss. 3
Closed Access | Times Cited: 28
Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents
Pilli Govindaiah, Naresh Dumala, Paramjit Grover, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 14, pp. 1819-1824
Closed Access | Times Cited: 28
Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect
Tarek S. Ibrahim, Mohamed M. Hawwas, Azizah M. Malebari, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 802-818
Open Access | Times Cited: 20
Breaking malignant nuclei as a non-mitotic mechanism of taxol-paclitaxel
Elizabeth R. Smith, Xiang‐Xi Xu
Journal of Cancer Biology (2021) Vol. 2, Iss. 4
Open Access | Times Cited: 20
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
Joan Tymon‐Rosario, Naomi Adjei, Dana M. Roque, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6239-6239
Open Access | Times Cited: 20
Novel Indole-Containing Hybrids Derived from Millepachine: Synthesis, Biological Evaluation and Antitumor Mechanism Study
Baoxia Liang, Qing Zou, Lintao Yu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1481-1481
Open Access | Times Cited: 8
Microtubule stabilization targeting regenerative chondrocyte cluster for cartilage regeneration
Jiawei Li, Chunmei Fan, Zhongyang Lv, et al.
Theranostics (2023) Vol. 13, Iss. 10, pp. 3480-3496
Open Access | Times Cited: 7
Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer
Shuangshuang Xiong, Ke Song, Hua Xiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116393-116393
Closed Access | Times Cited: 2
Synthesis of Estrone Heterodimers and Evaluation of Their In Vitro Antiproliferative Activity
Noémi Bózsity, Viktória Nagy, Johanna Szabó, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4274-4274
Open Access | Times Cited: 2
Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer
Vidhi Shah, Duc X. Nguyen, Adel Al Fatease, et al.
Journal of Controlled Release (2018) Vol. 291, pp. 169-183
Closed Access | Times Cited: 24
Therapeutic potential of marine peptides in malignant melanoma
Salman Ahmed, Waqas Alam, Khalaf F. Alsharif, et al.
Environmental Research (2023) Vol. 227, pp. 115771-115771
Closed Access | Times Cited: 7
Organotin benzohydroxamate derivatives (OTBH) target colchicine-binding site exerting potent antitumor activity both in vitro and vivo revealed by quantitative proteomic analysis
Jiayu Song, Shuran Liu, Yuan Ren, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 187, pp. 106488-106488
Open Access | Times Cited: 7
Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization
Romeo Romagnoli, Filippo Prencipe, Paola Oliva, et al.
Bioorganic Chemistry (2020) Vol. 97, pp. 103665-103665
Open Access | Times Cited: 18
Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors
Shuai Wen, Xinnan Li, Wenlong Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 197, pp. 112308-112308
Open Access | Times Cited: 18
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents
Romeo Romagnoli, Paola Oliva, María Kimatrai Salvador, et al.
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113229-113229
Open Access | Times Cited: 16
Identifying a novel anticancer agent with microtubule-stabilizing effects through computational cell-based bioactivity prediction models and bioassays
Yao Luo, Ranran Zeng, Qingqing Guo, et al.
Organic & Biomolecular Chemistry (2019) Vol. 17, Iss. 6, pp. 1519-1530
Closed Access | Times Cited: 18

Scroll to top